<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="case-report" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OURD</journal-id>
<journal-title>Our Dermatol Online</journal-title>
<issn pub-type="epub">2081-9390</issn>
<publisher>
<publisher-name>Our Dermatology Online</publisher-name>
<publisher-loc>Poland</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">OURD-6-343</article-id>
<article-id pub-id-type="doi">10.7241/ourd.20153.92</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Infantile Haemangioma &#x2013; An unusual location</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Inakanti</surname>
<given-names>Yugandar</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="corresp" rid="cor1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rao</surname>
<given-names>Thimmasarthi Venkata Narsimha</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><italic>Department of Dermatology, Venerology and Leprosy, P.E.S. Medical College, Kuppam, India</italic></aff>
<aff id="aff2"><label>2</label><italic>Department of Dermatology, Venerology and Leprosy, Guntur Medical College, Guntur, India</italic></aff>
<author-notes>
<corresp id="cor1">
<bold>Corresponding author:</bold> Dr. Yugandar Inakanti, E-mail: <email xlink:href="dryugandar@gmail.com">dryugandar@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<year>2015</year>
</pub-date>
<volume>6</volume>
<issue>3</issue>
<fpage>343</fpage>
<lpage>346</lpage>
<history>
<date date-type="received"><day>05</day><month>01</month><year>2015</year></date>
<date date-type="accepted"><day>17</day><month>04</month><year>2015</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x000a9; Our Dermatol Online 3</copyright-statement>
<copyright-year>2015</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
</license>
</permissions>
<abstract>
<p>Infantile haemangiomas (IH) are benign vascular neoplasms that have a characteristic clinical course marked by early proliferation and followed by spontaneous involution. Haemangiomas are the most common tumours of infancy and usually are medically insignificant. Cutaneous haemangiomas at particular sites is more common at Head and neck followed by Trunk and Extremities. Extra cutaneous haemangiomas were more common in Liver, Gastrointestinal tract, Larynx, Central nervous system, Pancreas and Lungs. We represent an 8-month-old boy presented with a small but growing, strawberry-colour tumour over the right groin since birth.</p>
</abstract>
<kwd-group>
<kwd>Cutaneous vasculature</kwd>
<kwd>Groin</kwd>
<kwd>Haemangiomas</kwd>
<kwd>Vascular malformations</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-1" sec-type="intro">
<title>INTRODUCTION</title>
<p>A &#x201C;haemangioma&#x201D;(Greek for blood-vessel-growth) of Infancy is a benign overgrowth of blood vessel cells in the skin. It is also known as proliferative haemangioma because it is due to proliferating endothelial cells; these are the cells that line blood vessels. The incidence ranges from 1&#x0025; in neonates to 12&#x0025; [<xref ref-type="bibr" rid="ref1">1</xref>]. These are known to appear soon after birth, proliferate for 8-18 months, and then slowly regress over the next 5-8 years, leaving behind normal or slightly blemished skin [<xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref3">3</xref>].</p>
<p>Haemangiomas are common birthmarks which are usually red or purple. They mostly occur on the head and neck areas and develop shortly after birth. One in 10 babies will develop a haemangioma and it is more common in girls. In literature of Dermatology, groin has been cited unusual site of occurrence.</p>
</sec>
<sec id="sec1-2" sec-type="cases">
<title>CASE REPORT</title>
<p>An 8-month-old boy presented with a small but growing, strawberry-colour tumor over the right side of the groin. The mass had been present since birth, now measuring approximately 4 &#x00D7; 3 cm of Circular in shape. The parents were concerned about the tumours growth and appearance.</p>
<p>The boy had been born prematurely at 34 weeks&#x2019; gestation after premature contractions and prolonged rupture of membranes. No maternal fever, tachycardia, chorioamnionitis, or other complications had occurred. The boy had stayed in neonatal intensive care for 4 weeks because of feeding issues, and he had been transiently on nasal continuous positive airway pressure therapy, from which he was weaned to room air after 3 days of life. He was discharged at 38 weeks&#x2019; gestation. When the child had reached approximately 6 months of age, he had begun to scratch the haemangioma and rub it against toys and other items, resulting in severe ulceration of the lesion. The parents were anxious about the tumour&#x2019;s rapid growth, and bleeding from minor trauma.</p>
<p>On admission, a thorough physical examination showed tumours growth of oval to circular in shape with diameter of 4 &#x00D7; 3 cm with red in colour over the right side of groin (Figs <xref ref-type="fig" rid="F1">1</xref> and <xref ref-type="fig" rid="F2">2</xref>). Single linear ulcer with well defined borders of size 1cm was seen over tumourous growth. No other areas of body affected.</p>
<fig id="F1">
<label>Figure 1</label>
<caption>
<p>Multiple tumorous growth over right side of groin</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-6-343-g001.tif"/>
</fig>
<fig id="F2">
<label>Figure 2</label>
<caption>
<p>Linear ulcer with well-defined border over tumorous growth.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-6-343-g002.tif"/>
</fig>
<p>The possible differential diagnoses are</p>
<p>
<list list-type="order">
<list-item>
<p>Cherry Haemangioma</p>
</list-item>
<list-item>
<p>Cobb Syndrome</p>
</list-item>
<list-item>
<p>Lipomas</p>
</list-item>
<list-item>
<p>Capillary Malformation</p>
</list-item>
<list-item>
<p>Lymphangiomas</p>
</list-item>
<list-item>
<p>Lobular Capillary Haemangioma)</p>
</list-item>
</list>
</p>
<p>Routine Laboratory investigations followed by electrocardiogram, chest x-ray and local ultrasonography of the lesion using a high frequency probe. Laboratory investigations were within normal limits.</p>
<p>After discussing with parents and with their consent, Punch biopsy was performed.</p>
<p>Histopathological examination of the specimen showed the Para keratinised stratified Squamous epithelium of varying thickness and the fibrous connective tissue with numerous endothelial lined capillaries of varied size and few blood vessels, which were yet to be lumenized (Figs <xref ref-type="fig" rid="F3 F4">3</xref>-<xref ref-type="fig" rid="F5">5</xref>). Tumour of the blood vessels of capillary calibre (no elastic fibres nor smooth muscle within the wall, size is variable) and undifferentiated endothelia. Diagnosis of capillary haemangioma was confirmed.</p>
<fig id="F3">
<label>Figure 3</label>
<caption>
<p>Para keratinised stratified Squamous epithelium of varying thickness and the fibrous connective tissue with numerous endothelial lined capillaries of varied size.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-6-343-g003.tif"/>
</fig>
<fig id="F4">
<label>Figure 4</label>
<caption>
<p>Fibrous tissue in between capillaries.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-6-343-g004.tif"/>
</fig>
<fig id="F5">
<label>Figure 5</label>
<caption>
<p>Endothelial cells lining capillaries.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-6-343-g005.tif"/>
</fig>
<p>After evaluating the boy and noting the haemangioma location and because of parent&#x2019;s anxiety and apprehension the boy was referred to paediatric surgery.</p>
<p>Prior to the study, patient gave written consent to the examination and biopsy after having been informed about the procedure.</p>
</sec>
<sec id="sec1-3" sec-type="discussion">
<title>DISCUSSION</title>
<p>IH is a benign, self-involuting tumour of endothelial cells that usually appears during the first weeks to months of life [<xref ref-type="bibr" rid="ref4">4</xref>]. It is one of the most common birthmarks among newborns. Most infantile haemangiomas reach a maximum size of 0.5-5 cm, but they can range from the size of a pinhead to greater than 20cm in diameter. Most infantile haemangiomas remain well circumscribed and focal. Haemangiomas are found in up to 10&#x0025; of children by the age of 1 year and are more common in girls and premature infants. Their cause is unknown. In very rare instances, they may run in families, but they generally are not inherited.</p>
<p>Infantile haemangiomas are classified as superficial, deep or mixed lesions.</p>
<p>
<list list-type="bullet">
<list-item>
<p>The superficial infantile haemangiomas is also called capillary haemangioma, capillary naevus, strawberry haemangioma, strawberry naevus, and haemangioma simplex. The blood vessels in uppermost layers of the skin are dilated.</p>
</list-item>
<list-item>
<p>Deep infantile haemangiomas are also called cavernous haemangiomas and are more deeply set in the dermis and sub cutis. They appear as a bluish soft to firm swelling.</p>
</list-item>
<list-item>
<p>Both types of haemangiomas may occur together in mixed angiomatous naevi. A strawberry naevus overlies a bluish swelling.</p>
</list-item>
</list>
</p>
<p>Another variant is the infantile haemangioma with minimal or arrested growth (IH-MAG). These have been previously referred to as abortive, reticular, or telangiectatic IH. This variant has been seen in association with underlying vascular and other extracutaneous congenital anomalies PHACE and PELVIS syndromes [<xref ref-type="bibr" rid="ref5">5</xref>].</p>
<p>Regulators of haemangioma growth and involution are poorly understood. During the growth phase, two major proangiogenic factors are involved: basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) [<xref ref-type="bibr" rid="ref6">6</xref>]. Potential explanations for the therapeutic effect of propranolol (a non-selective beta-blocker) on IH include: vasoconstriction, which is immediately visible as a change in colour, associated with a palpable softening of the haemangioma; decreased expression of VEGF and bFGF genes through the down regulation of the RAF-mitogen -activated protein kinase pathway [<xref ref-type="bibr" rid="ref7">7</xref>]. The response of IH to propanolol has been reported by L&#x00E9;aut&#x00E9;-Labr&#x00E8;ze et al [<xref ref-type="bibr" rid="ref8">8</xref>].</p>
<p>IH usually involutes over time: 30&#x0025; resolve by 3 years of age, 50&#x0025; by 5 years of age, and 80&#x0025; to 90&#x0025; by 9 years of age. More than half of haemangiomas heal with excellent cosmetic results without treatment. Nevertheless, some haemangiomas require treatment, such as when a vital organ (e.g. eye, ear, trachea) is involved; when bleeding, ulceration, crusting, or infection is present; or when their rapid growth leads to deformity of surrounding tissues. IH in certain areas, particularly the face (especially the nose and lips), body folds, and groin, have a higher risk of complications.</p>
<p>The vast majority of IH do not require any medical or surgical intervention. Medical care of clinically significant IH has been limited to a few medications, including glucocorticosteroids (topical, intralesional and oral), interferon alfa [<xref ref-type="bibr" rid="ref9">9</xref>] and, rarely, vincristine and topical Imiquimod [<xref ref-type="bibr" rid="ref10">10</xref>]. Beta-blockers, most specifically propanolol, [<xref ref-type="bibr" rid="ref11">11</xref>] have serendipitously been shown to induce involution of IH [<xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref12">12</xref>] Pulse dyed laser surgery, [<xref ref-type="bibr" rid="ref13">13</xref>] other lasers frequency-doubled ND: YAG, and KTP lasers.</p>
<p>Certain benefits to early surgical excision include saving a life or preserving vision if it is near to eye and decreasing the negative psychosocial effects associated with a cosmetically disfiguring lesion during early childhood.</p>
</sec>
<sec id="sec1-4" sec-type="conclusion">
<title>CONCLUSION</title>
<p>To our best of knowledge, this is the first reported case of a capillary haemangioma occurring in this location. We describe case of capillary haemangiomas, concluding that despite the rarity of these lesions, they should be considered in the differential diagnosis of lesions in the groin region.</p>
</sec>
<sec id="sec1-5">
<title>CONSENT</title>
<p>Written informed consent was obtained from the patient guardian for publication of this case report and any accompanying images. The examination of patients is conducted according to the Declaration of Helsinki principles.</p>
</sec>
</body>
<back>
<ref-list>
<title>REFERENCES</title>
<ref id="ref1">
<label>1</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Panda</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bajpai</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Use of oral prednisolone with or without propranolol in the management of infantile hemangioma: A critical appraisal</article-title>
<source>Indian J Paediatric Dermatol</source>
<year>2013</year>
<volume>14</volume>
<fpage>19</fpage>
<lpage>22</lpage>
</nlm-citation>
</ref>
<ref id="ref2">
<label>2</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mishra</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Bishen</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Yadav</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Capillary hemangioma: An occasional growth of attached gingiva</article-title>
<source>J Indian Soc Periodontol</source>
<year>2012</year>
<volume>16</volume>
<fpage>592</fpage>
<lpage>6</lpage>
</nlm-citation>
</ref>
<ref id="ref3">
<label>3</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jadhav</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>Tolat</surname>
<given-names>SN</given-names>
</name>
</person-group>
<article-title>Dramatic response of propranolol in hemangioma: Report of two cases</article-title>
<source>Indian J Dermatol Venereol Leprol</source>
<year>2010</year>
<volume>76</volume>
<fpage>691</fpage>
<lpage>4</lpage>
</nlm-citation>
</ref>
<ref id="ref4">
<label>4</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sachdeva</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kaur</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nagpal</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dewan</surname>
<given-names>SP</given-names>
</name>
</person-group>
<article-title>Cutaneous lesions in new born</article-title>
<source>Indian J Dermatol Venereol Leprol</source>
<year>2002</year>
<volume>68</volume>
<fpage>334</fpage>
<lpage>7</lpage>
</nlm-citation>
</ref>
<ref id="ref5">
<label>5</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suh</surname>
<given-names>KY</given-names>
</name>
<name>
<surname>Frieden</surname>
<given-names>IJ</given-names>
</name>
</person-group>
<article-title>Infantile hemangiomas with minimal or arrested growth: a retrospective case series</article-title>
<source>Arch Dermatol</source>
<year>2010</year>
<volume>146</volume>
<fpage>971</fpage>
<lpage>6</lpage>
</nlm-citation>
</ref>
<ref id="ref6">
<label>6</label>
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Frieden</surname>
<given-names>IJ</given-names>
</name>
<name>
<surname>Haggstrom</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Drolet</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Mancini</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Friedlander</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Boon</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Infantile hemangiomas: current knowledge, future directions: Proceedings of a research workshop on infantile hemangiomas, April 7-9, 2005</article-title>
<source>Pediatr Dermatol</source>
<year>2005</year>
<volume>22</volume>
<publisher-loc>Maryland, USA</publisher-loc>
<publisher-name>Bethesda</publisher-name>
<fpage>383</fpage>
<lpage>6</lpage>
</nlm-citation>
</ref>
<ref id="ref7">
<label>7</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sulpice</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bryckaert</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lacour</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Contreres</surname>
<given-names>JO</given-names>
</name>
<name>
<surname>Gerard</surname>
<given-names>Tobelem</given-names>
</name>
</person-group>
<article-title>Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal&#x2013;regulated kinase pathway but not by the phosphatidylinositol 3&#x2013;kinase pathway</article-title>
<source>Blood</source>
<year>2002</year>
<volume>100</volume>
<fpage>3087</fpage>
<lpage>94</lpage>
</nlm-citation>
</ref>
<ref id="ref8">
<label>8</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>L&#233;aut&#233;-Labr&#232;ze</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dumas de la</surname>
<given-names>Roque E</given-names>
</name>
<name>
<surname>Hubiche</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Boralevi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Thambo</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Ta&#239;eb</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Propranolol for severe hemangiomas of infancy</article-title>
<source>N Engl J Med</source>
<year>2008</year>
<volume>358</volume>
<fpage>2649</fpage>
<lpage>51</lpage>
</nlm-citation>
</ref>
<ref id="ref9">
<label>9</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Musumeci</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Schlecht</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Perrotta</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>Management of Cutaneous Hemangiomas in Pediatric Patients</article-title>
<source>Cutis</source>
<year>2008</year>
<volume>81</volume>
<fpage>315</fpage>
<lpage>2</lpage>
</nlm-citation>
</ref>
<ref id="ref10">
<label>10</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akinbami</surname>
<given-names>BO</given-names>
</name>
<name>
<surname>Omitola</surname>
<given-names>OG</given-names>
</name>
<name>
<surname>Akadiri</surname>
<given-names>OA</given-names>
</name>
</person-group>
<article-title>Pattern of presentation and management of orofacial and neck soft tissue tumors in a Nigerian tertiary health center &#x2013; a preliminary study</article-title>
<source>Intern Med Inside</source>
<year>2013</year>
<volume>1</volume>
<fpage>9</fpage>
</nlm-citation>
</ref>
<ref id="ref11">
<label>11</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Price</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Lattouf</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Baum</surname>
<given-names>B</given-names>
</name>
<name>
<surname>McLeod</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schachner</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Duarte</surname>
<given-names>AM</given-names>
</name>
<etal/>
</person-group>
<article-title>Propranolol vs Corticosteroids for Infantile Hemangiomas: A Multicenter Retrospective Analysis</article-title>
<source>Arch. Dermatol</source>
<year>2011</year>
<volume>147</volume>
<fpage>1371</fpage>
<lpage>6</lpage>
</nlm-citation>
</ref>
<ref id="ref12">
<label>12</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siegfried</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Keenan</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Al-Jureidini</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>More on propranolol for hemangiomas of infancy</article-title>
<source>N Engl J Med</source>
<year>2008</year>
<volume>359</volume>
<fpage>2846</fpage>
<lpage>7</lpage>
</nlm-citation>
</ref>
<ref id="ref13">
<label>13</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Srinivas</surname>
<given-names>C R</given-names>
</name>
<name>
<surname>Kumaresan</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Lasers for vascular lesions: Standard guidelines of care</article-title>
<source>Indian J Dermatol Venereol Leprol</source>
<year>2011</year>
<volume>77</volume>
<fpage>349</fpage>
<lpage>68</lpage>
</nlm-citation>
</ref>
</ref-list>
<fn-group>
<fn fn-type="supported-by">
<p><bold>Source of Support:</bold> Nil,</p>
</fn>
<fn fn-type="conflict">
<p><bold>Conflict of Interest:</bold> None declared.</p>
</fn>
</fn-group>
</back>
</article>